Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | TRMOY | FTAI |
|---|---|---|
| Price | $14.50 | $164.70 |
| Change today | ▼ 3.33% | ▼ 1.40% |
| Market cap | $16.90B | $16.92B |
| Return, 3 months | – | -27.5% |
| Return, year to date | – | -15.9% |
| Return, 1 year | – | -3.2% |
| P/E (TTM) | 65.9 | 36.0 |
| P/B | 1.5 | 41.9 |
| P/E percentile vs own 5y | – | 57th |
| Dividend yield | 2.44% | 0.91% |
| Revenue growth (YoY, latest qtr) | – | +40.9% |
| Net profit growth (YoY) | – | -24.4% |
| Gross margin | – | 32.5% |
| Operating margin | – | 25.2% |
| Net margin | – | 15.3% |
| Return on equity | – | 167.9% |
| Analyst target vs. price | – | +101.6% |
| Analyst buy share | – | 100% |
| RSI (14) | 29 | 34 |
| 30-day volatility | 10.2% | 51.8% |
| Max drawdown, 1 year | -26.9% | -46.6% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
